April 1, 2009 - Demasq Limited (Demasq), a spin-off of Fusion IP plc, a university IP commercialization company, has gained FDA and CE clearance to market its Knee Imaging Software (KIS), a bone and soft tissue imaging solution.
KIS aims to provide surgeons, radiologists, physiotherapists and GPs with an enhanced image quality, similar to that of the soft tissue detail achievable with MRI combined with the bone detail of an X-ray, at a lower cost when compared to conventional imaging technologies.
The KIS system analyzes X-rays created by digital X-ray systems and is capable of accepting all common digital file formats via an existing PACS (Picture Archive and Communication System) network. The image created will depict detail of the bone and soft tissues of the knee joint and can be used to identify detail that is not currently readily visible on a grayscale digital X-ray image.
To assist interpretation the interface will allow the end-user to crop, zoom, rotate, measure and save the image. Images can be saved to a desktop or PACS network as standard files formats. A library of case studies will also be provided to aid training and interpretation.
KIS now has both CE and FDA approval and Demasq plans to launch KIS in the U.K. and U.S. in H2 2009.
For more information: www.demasq.com
June 15, 2026 
